GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Onward Medical NV (XBRU:ONWD) » Definitions » Selling and Marketing Expense

Onward Medical NV (XBRU:ONWD) Selling and Marketing Expense : €1.11 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Onward Medical NV Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. Onward Medical NV's Selling and Marketing Expense for the six months ended in Dec. 2023 was €-0.46 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Dec. 2023 was €1.11 Mil.

Onward Medical NV Selling and Marketing Expense Historical Data

The historical data trend for Onward Medical NV's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Onward Medical NV Selling and Marketing Expense Chart

Onward Medical NV Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Selling and Marketing Expense
Get a 7-Day Free Trial 0.26 0.39 1.52 1.00 1.11

Onward Medical NV Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Selling and Marketing Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.16 0.87 0.14 1.57 -0.46

Onward Medical NV Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €1.11 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Onward Medical NV Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of Onward Medical NV's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Onward Medical NV (XBRU:ONWD) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Onward Medical NV (XBRU:ONWD) » Definitions » Selling and Marketing Expense
Comparable Companies
XBRU:ALIMG XBRU:CYAD XBRU:BIOS XBRU:OXUR XBRU:HYL OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX SZSE:300122 BGNE ALNY OCSE:GMAB BMRN
Traded in Other Exchanges
ONWRF:USA 63E:Germany
Address
High Tech Campus 32, Noord-Braban, Eindhoven, NH, NLD, NL-5656 AE
Website
https://www.onwd.com
Onward Medical NV is a medical technology company developing and commercializing therapies to enable functional recovery for people with spinal cord injury. It has developed two programmable neurostimulation platforms: an implantable system, ARCIM, and a non-invasive, transcutaneous system, ARCEX. The company has selected the United states and four European markets: Germany, France, the UK and the Netherlands to create a customer base.

Onward Medical NV (XBRU:ONWD) Headlines

No Headlines